Indeed, there is wide evidence that the use of GLP-1 RAs in T2DM patients is associated with a lower incidence of depression and anxiety compared to controls treated with different therapies [23, 48, 49]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.